MORE THAN 50 years ago, investigators observed that the thymus gland undergoes hypertrophy in association with adrenocortical insufficiency and atrophy in association with adrenocortical excess.1,2 These observations led to the realization that adrenal corticosteroids (ACS) have a “lympholytic effect,” which in turn stimulated clinical investigators to treat lymphomas with ACS for the first time in the late 1940s.3,4Today, we know that ACS do not directly lyse thymocytes and lymphoma cells, but rather induce apoptosis.5 Apoptosis, or programmed cell death, is a genetically regulated process in which the cell is active in producing its own death, a type of cellular suicide for the sake of maintaining homeostasis in the cellular community.6-8 

Although our understanding of apoptosis has advanced tremendously in recent years, the mechanism by which ACS induce apoptosis in thymocytes and lymphoma cells is not completely understood. In the 1970s, Sibley and Tompkins determined that the initial step in ACS-induced apoptosis is mediated through the ACS receptor and requires translocation of the receptor from the cytoplasm into the nucleus.9 In the nucleus, the ACS receptor functions as a transcription factor, enhancing or repressing the expression of a selected repertoire of genes.10 ACS may repress expression of genes necessary for cell survival by attenuating AP-1 (c-Fos/c-Jun) transcription factor activity,11 or may induce the transcription of genes involved in carrying out the death program. The evidence in support of the latter concept is twofold: first, inhibitors of RNA and protein synthesis inhibit ACS-induced apoptosis12,13; and second, the transactivation domain of the ACS receptor is required for apoptosis induction by ACS.14 

Progress in identifying ACS-inducible genes that mediate apoptosis had been slow. Now, in the past year, two ACS-inducible genes have been formally implicated in mediating apoptosis. One of the genes encodes a purinergic receptor, P2X1, that functions as an ATP-gated calcium channel,15 whereas the other gene encodes an inositol 1,4,5-trisphosphate receptor (IP3R) that functions as an IP3-gated calcium channel.16 The fact that both of these genes encode calcium channels has reawakened interest in the role of calcium, a major intracellular second messenger molecule, as a mediator of apoptosis. In this review, we first summarize the evidence for involvement of these genes in apoptosis. Then, we attempt to integrate these novel findings with previous experimental evidence suggesting a role for calcium in signaling glucocorticoid-induced apoptosis in both thymocytes and lymphoma cells.

Recognition that purinergic receptors are involved in ACS-induced apoptosis evolved out of an effort by Owens et al17 to identify differentially expressed mRNAs associated with ACS-induced apoptosis in thymocytes. One of the differentially expressed mRNAs identified by these investigators, termed RP-2, was induced early in the course of ACS-induced apoptosis. However, the identity of the RP-2 sequence was not elucidated until 5 years later, when it was discovered that RP-2 corresponds to a partial sequence of a gene encoding an ATP-gated cation channel, termed purinergic receptor or P2X receptor.18,19 This discovery is particularly intriguing, because extracellular ATP has been reported to induce apoptosis in thymocytes by increasing the intracellular concentration of calcium.20 21 

The P2X receptors constitute a family of at least seven members, distributed throughout central and peripheral neurons, smooth muscles, epithelia, developing skeletal neuromuscular junctions, lymphocytes, platelets, and macrophages. P2X receptors are nonselective cation channels with significant permeability to calcium. P2X receptors engage in intercellular communication by detecting the regulated (synaptic) or lytic (cell death) release of intracellular metabolites such as ATP. Unlike other well-known ion channels gated by extracellular ligands (eg, nicotinic, serotonin, 5-HT3), P2X receptors are characterized by only two transmembrane domains with intracellular amino- and carboxy-termini.22 RP-2 corresponds to the subfamily member P2X1 (originally termed P2XR1), recently cloned from vas deferens and PC12 cells.18 19 Curiously, P2X receptors are structurally similar to some of theCaenorhabditis elegans gene products implicated in neuronal cell selection and death.

The link between P2X1 receptor expression and ACS-induced apoptosis in rat thymocytes was recently established by Chvatchko et al.15 These investigators found that P2X1receptors were upregulated in thymocytes during ACS-induced apoptosis. Furthermore, extracellular ATP enhanced ACS-induced apoptosis and antagonists of ATP substantially reduced ACS-induced apoptosis, suggesting that ACS-induced apoptosis is dependent on P2X1receptor activation by extracellular ATP.

The other ACS-inducible gene implicated in mediating apoptosis of both thymocytes and lymphoma cells encodes the Type 3 IP3R.16 The IP3R has been extensively characterized and plays a central role in calcium signaling.23,24 Typically, IP3 generated in response to G-protein–coupled receptors and receptor tyrosine kinases binds to the IP3 receptor that spans the endoplasmic reticulum (ER) membrane.23,24 The binding of IP3 induces transient opening of the receptor, allowing calcium to flow from the ER lumen into the cytoplasm, thereby producing a transient elevation of cytosolic calcium that in turn activates signal transduction kinases. Although IP3R are most prominently located on the ER membrane, there is evidence for localization of the IP3R to the plasma membrane, enabling the IP3R to mediate entry of extracellular calcium into the cytoplasm16 (and references therein). In cells undergoing apoptosis in response to ACS, immunocytochemical studies localized the IP3R (specifically subtype 3) to the plasma membrane.16 Upregulation of IP3R in S49 lymphoma cells was associated with increased cytosolic calcium concentration, suggesting that increased expression of IP3R on the plasma membrane increased calcium entry.16Significantly, repression of ACS-induced IP3R expression by transfecting cells with an IP3R antisense plasmid not only decreased the induction of IP3R, but also inhibited the induction of apoptosis by ACS.16 

The involvement of calcium in ACS-induced apoptosis was first suggested by Kaiser and Edelman,25 who discovered that extracellular calcium is necessary for induction of apoptosis in thymocytes by ACS. This observation, which has been confirmed by others,12,13suggests that extracellular calcium uptake mediates ACS-induced apoptosis. The concept that calcium signals ACS-induced apoptosis is further supported by evidence that the calmodulin inhibitor, calmidazolium, interferes with ACS-induced thymocyte apoptosis.26,27 However, in contrast to the situation in thymocytes, extracellular calcium is unnecessary for ACS-induced apoptosis of peripheral lymph node lymphocytes and lymphoma cells.28-33 

These earlier findings are fully consistent with the patterns of expression of the P2X1 receptor. P2X1expression was detected in thymocytes, but not in peripheral (lymph node) T lymphocytes.15 Furthermore, there is a strong correlation between P2X1 expression and the susceptibility of individual thymocyte subsets to ACS-induced apoptosis. In the thymus gland, immature CD4+CD8+ thymocytes residing within the cortex are programmed to undergo apoptosis in response to ACS, whereas the more mature CD4+CD8 or CD4CD8+ thymocytes located in the medulla and circulating T lymphocytes are less sensitive to ACS-induced apoptosis.34-37 Significantly, P2X1 expression was detected only in CD4+CD8+ thymocytes, but not in peripheral (lymph node) T lymphocytes.15 

The earlier findings suggesting a role of extracellular calcium in mediating ACS-induced apoptosis of thymocytes are also consistent with evidence that ACS treatment increases the expression of the Type 3 IP3R in cortical, but not medullary, thymocytes.16 However, evidence that ACS induce the expression of Type 3 IP3R on the plasma membrane of S49 cells, a T-cell lymphoma line,16 appears to be less consistent with earlier evidence indicating the extracellular calcium is not required for induction of apoptosis in lymphoma cells by ACS.29-32 Moreover, it is possible that the localization of the IP3R to plasma membrane was a consequence of apoptotic bleb formation in ACS-treated lymphoma cells. The apoptotic blebs that form at the cell surface during apoptosis are membranous structures composed of ER membrane.38 Thus, further work will be required to determine whether IP3R induced by ACS treatment are located primarily on the plasma membrane, or are located on the ER membrane and then relocated to the cell surface as apoptotic blebs form.

Although there is considerable evidence that extracellular calcium is not required for apoptosis induction by ACS in lymphoma cells, a role for calcium in mediating ACS-induced apoptosis of lymphoma cells has been supported by several findings. First, calmodulin gene expression is increased in T-cell lymphoma cells after treatment with ACS.27 Second, calmidazolium interferes with apoptosis in ACS-treated lymphoma cells.27 Third, stable expression of a cDNA encoding the high-affinity calcium-binding protein, calbindin, inhibited ACS-induced apoptosis in lymphoma cells.39 Where, then, might the calcium come from that mediates ACS-induced apoptosis in these cells? We and others have detected a diminution of the ER calcium pool in ACS-treated lymphoma cells.33 40 Thus, one theory is that calcium release from the ER, perhaps via IP3R located on the ER membrane, may be involved in signaling apoptosis in ACS-treated lymphoma cells.

Although the novel findings of the past year have provided molecular evidence of a role for calcium in ACS-induced apoptosis, the specific role that calcium plays in death induction and the signal transduction pathway initiated by cytosolic calcium elevation and how it leads to apoptosis are unknown. In the case of T-cell receptor (TCR)-mediated apoptosis, calcium in combination with calmodulin activates calcineurin, a cytosolic protein phosphatase that dephosphorylates and thereby activates the transcription factor NF-ATC, leading to increased transcription of calcium-regulated, immediate-early genes, including Nur77.41 Calcineurin function, and hence TCR-mediated apoptosis, is inhibited by the potent immunosuppressants cyclosporin A and FK506.42 However, these agents do not inhibit ACS-induced apoptosis.42 Furthermore, ACS- and TCR-mediated apoptotic pathways are mutually antagonistic42and calcineurin activation protects T cells from ACS-induced apoptosis.43 Also, Nur77 is not significantly induced by ACS.41 One possible lead is a recently identified calcium-binding protein, ALG-2, that has been implicated as necessary for ACS-induced apoptosis, but its precise role in the apoptotic process has not been defined.44 

Another concept deserving further consideration is that while calcium mediates apoptosis of ACS-treated cells, it might not be necessary for ACS-induced cell death. This concept is based on a recent report by Iseki et al,45 who found that high concentrations of the intracellular calcium chelator Quin-2/AM inhibited DNA fragmentation in ACS-treated thymocytes, but did not inhibit cell death. In their hands, calmodulin inhibitors blocked DNA fragmentation, but markedly enhanced cytolysis. One interpretation of these findings is that calcium might be required for DNA cleavage during apoptosis, but not for cell death. Thus, calcium might be involved in endonuclease activation, as part of the degradation phase of apoptosis, but might not be necessary for cell death.

However, the role of calcium in endonuclease activation varies among different types of lymphocytes. Whereas the endonuclease responsible for apoptotic DNA fragmentation in ACS-treated thymocytes requires calcium for maximal activity,5,13,31,46-49 DNA is cleaved by a calcium-independent endonuclease in the CEM human lymphoblast cell line.50 These observations correlate with the evidence that extracellular calcium uptake is required for ACS-induced thymocyte apoptosis, but not for ACS-induced apoptosis of lymphoma cell.12,13,25 28 

Another potential role for calcium in ACS-induced apoptosis might be in protease activation. The calcium-dependent neutral protease, calpain, is activated in the course of apoptosis induction in ACS-treated thymocytes, and a calpain inhibitor appears to inhibit ACS-induced thymocyte cell death.51 Moreover, destruction of the nuclear structural protein lamin, an event that appears to precede endonucleolytic DNA cleavage during ACS-induced apoptosis, is inhibited by a calpain inhibitor.52,53 Currently, there is little mechanistic insight into how ACS-induced cytosolic calcium elevation might lead to activation of interleukin-1β converting enzyme–like proteases, which clearly play a prominent role in ACS-induced apoptosis, as well as other forms of apoptosis.54 

Since the initial observations by Kaiser and Edelman,25 28interest in the role of calcium in ACS-induced apoptosis has wavered, in part because of the fact that extracellular calcium is only necessary for induction of apoptosis in thymocytes, but not in peripheral lymphocytes or lymphoma cells. Now, as a result of molecular evidence implicating two separate ligand-gated calcium channels in ACS-induced apoptosis, interest in the role of calcium is sure to be renewed. The major challenge lies in determining the signal transduction pathway through which ACS-induced calcium fluxes mediate apoptosis.

Recent results (Jayaraman T, Marks AR: Mol Cell Biol17:3005, 1997) indicate that T cells deficient in IP3RI are resistant to ACS-induced apoptosis, providing additional evidence for a role of calcium in signaling ACS-induced apoptosis.

Address reprint requests to Clark W. Distelhorst, MD, Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH, 44106-4937.

1
Dougherty
TF
White
A
Effect of pituitary adrenotropic hormone on lymphoid tissue.
Proc Soc Exp Biol Med
53
1943
132
2
Heilman
RR
Kendall
EC
The influence of 11-dehydro-17-hydroxy-corticosterone (compound E) on the growth of a malignant tumor in the mouse.
Endocrinology
34
1944
416
3
Pearson
OH
Eliel
LP
Rawson
RW
Dobriner
K
Rhoads
CP
ACTH- and cortisone-induced regression of lymphoid tumors in man: A preliminary report.
Cancer
2
1949
943
4
Pearson
OH
Eliel
LP
Use of pituitary adrenocorticotropic hormone (ACTH) and cortisone in lymphomas and leukemias.
JAMA
144
1950
1349
5
Wyllie
AH
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.
Nature
284
1980
555
6
Raff
MC
Social controls on cell survival and cell death.
Nature
356
1992
397
7
Thompson
CB
Apoptosis in the pathogenesis and treatment of disease.
Science
267
1995
1456
8
Yang
E
Korsmeyer
SJ
Molecular thanatopsis: A discourse on the BCL2 family and cell death.
Blood
88
1996
386
9
Sibley
CH
Tompkins
GM
Isolation of lymphoma cell variants resistant to killing by glucocorticoids.
Cell
2
1974
213
10
Beato
M
Gene regulation by steroid hormones.
Cell
56
1989
335
11
Helmberg
A
Auphan
N
Caelles
C
Karin
M
Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor.
EMBO J
14
1995
452
12
Wyllie
AH
Morris
RG
Smith
AL
Dunlop
D
Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis.
J Pathol
142
1984
67
13
Cohen
JJ
Duke
RC
Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death.
J Immunol
132
1984
38
14
Dieken
ES
Miesfeld
RL
Transcriptional transactivation functions localized to the glucocorticoid receptor N terminus are necessary for steroid induction of lymphocyte apoptosis.
Mol Cell Biol
12
1992
589
15
Chvatchko
Y
Valera
S
Aubry
J-P
Renno
T
Buell
G
Bonnefoy
J-Y
The involvement of an ATP-gated ion channel, P2X1, in thymocyte apoptosis.
Immunity
5
1996
275
16
Khan
AA
Soloski
MJ
Sharp
AH
Schilling
G
Sabatini
DM
Li
S-H
Ross
CA
Snyder
SH
Lymphocyte apoptosis: Mediation by increased type 3 inositol 1,4,5,-trisphosphate receptor.
Science
273
1996
503
17
Owens
GP
Hahn
WE
Cohen
JJ
Identification of mRNAs associated with programmed cell death in immature thymocytes.
Mol Cell Biol
11
1991
4177
18
Brake
AJ
Wagenbach
MJ
Julius
D
New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor.
Nature
371
1994
519
19
Valera
S
Hussy
N
Evans
RJ
Adami
N
North
RA
Surprenant
A
Buell
G
A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP.
Nature
371
1994
516
20
Pizzo
P
Zanovello
P
Bronte
V
Di Virgilio
F
Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel.
Biochem J
274
1991
139
21
Zheng
LM
Zychlinsky
A
Liu
C-C
Ojcius
DM
Young
JD-E
Extracellular ATP as a trigger for apoptosis or programmed cell death.
J Cell Biol
112
1991
279
22
North
RA
Families of ion channels with two hydrophobic segments.
Curr Opin Cell Biol
8
1996
474
23
Berridge
MJ
Inositol trisphosphate and calcium signalling.
Nature
361
1993
315
24
Clapham
DE
Calcium signaling.
Cell
80
1995
259
25
Kaiser
N
Edelman
IS
Calcium dependence of glucocorticoid-induced lymphocytolysis.
Proc Natl Acad Sci USA
74
1977
632
26
McConkey
DJ
Nicotera
P
Hartzell
P
Bellomo
G
Wyllie
AH
Orrenius
S
Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration.
Arch Biochem Biophys
269
1989
365
27
Dowd
DR
MacDonald
PN
Komm
BS
Haussler
MR
Miesfeld
R
Evidence for early induction of calmodulin gene expression in lymphocytes undergoing glucocorticoid-mediated apoptosis.
J Biol Chem
266
1991
18423
28
Kaiser
N
Edelman
IS
Further studies on the role of calcium in glucocorticoid-induced lymphocytolysis.
Endocrinology
103
1978
936
29
Nicholson
ML
Young
DA
Effect of glucocorticoid hormones in vitro on the structural integrity of nuclei in corticosteroid-sensitive and -resistant lines of lymphosarcoma P1798.
Cancer Res
38
1978
3673
30
Nicholson
ML
Young
DA
Independence of the lethal actions of glucocorticoids on lymphoid cells from possible hormone effects on calcium uptake.
J Supramol Struct
10
1979
165
31
Alnemri
ES
Litwack
G
Glucocorticoid-induced lymphocytolysis is not mediated by an induced endonuclease.
J Biol Chem
264
1989
4104
32
Bansal
N
Houle
AG
Melnykovych
G
Dexamethasone-induced killing of neoplastic cells of lymphoid derivation: Lack of early calcium involvement.
J Cell Physiol
143
1990
105
33
Bian X, Hughes FM, Huang Y, Cidlowski JA, Putney JW: Roles of cytoplasmic Ca2+ and intracellular Ca2+ stores in induction and suppression of apoptosis in S49 cells. Am J Physiol 272 (Cell Physiol 41):C1241, 1997
34
Claman
HS
Corticosteroids and lymphoid cells.
N Engl J Med
287
1971
388
35
Ranelletti
FO
Piantelli
M
Iacobelli
S
Musiani
P
Longo
P
Lauriola
L
Marchetti
P
Glucocorticoid receptors and in vitro corticosensitivity of peanut-positive and peanut-negative human thymocyte subpopulations.
J Immunol
127
1981
849
36
Cederig
R
Dialynas
DP
Fitch
FW
MacDonald
HR
Precursors of T cell growth factor producing cells in the thymus.
J Exp Med
158
1983
1654
37
Cohen
JJ
Programmed cell death in the immune system.
Adv Immunol
50
1991
55
38
Casciola-Rosen
LA
Anhalt
G
Rosen
A
Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.
J Exp Med
179
1994
1317
39
Dowd
DR
MacDonald
PN
Komm
BS
Haussler
MR
Miesfeld
RL
Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes.
Mol Endocrinol
6
1992
1843
40
Lam
M
Dubyak
G
Distelhorst
CW
Effect of glucocorticosteroid treatment on intracellular calcium homeostasis in mouse lymphoma cells.
Mol Endocrinol
7
1993
686
41
Liu
Z-G
Smith
SW
McLaughlin
KA
Schwartz
LM
Osborne
BA
Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77.
Nature
367
1994
281
42
Zacharchuk
CM
Mercep
M
Chakraborti
PK
Simons
SS
Ashwell
JD
Programmed T lymphocyte death: Cell activation- and steroid-induced pathways are mutually antagonistic.
J Immunol
145
1990
4037
43
Zhao
Y
Tozawa
Y
Iseki
R
Mukai
M
Iwata
M
Calcineurin activation protects T cells from glucocorticoid-induced apoptosis.
J Immunol
154
1995
6346
44
Vito
P
Lacana
E
D'Adamio
LD
Interfering with apoptosis: Ca2+-binding protein ALG-2 and alzheimer's disease gene ALG-3.
Science
271
1996
521
45
Iseki
R
Kudo
Y
Iwata
M
Early mobilization of Ca2+ is not required for glucocorticoid-induced apoptosis in thymocytes.
J Immunol
151
1993
5198
46
Vedeckis
WV
Bradshaw
HDJ
DNA fragmentation in S49 lymphoma cells killed with glucocorticoids and other agents.
Mol Cell Endocrinol
30
1983
215
47
Jones
DP
McConkey
DJ
Nicotera
P
Orrenius
S
Calcium-activated DNA fragmentation in rat liver nuclei.
J Biol Chem
264
1989
6398
48
Gaido
ML
Cidlowski
JA
Identification, purification, and characterization of a calcium-dependent endonuclease (NUC18) from apoptotic rat thymocytes.
J Biol Chem
266
1991
18580
49
Ellis
RE
Yuan
J
Horvitz
HR
Mechanisms and functions of cell death.
Annu Rev Cell Biol
7
1991
663
50
Alnemri
ES
Litwack
G
Activation of internucleosomal DNA cleavage in human CEM lymphocytes by glucocorticoid and novobiocin.
J Biol Chem
265
1990
17323
51
Squier
MKT
Miller
ACK
Malkinson
AM
Cohen
JJ
Calpain activation in apoptosis.
J Cell Physiol
159
1994
229
52
Neamati
N
Fernanadez
A
Wright
S
Kiefer
J
McConkey
DJ
Degradation of lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei.
J Immunol
154
1995
3788
53
McConkey
DJ
Calcium-dependent, interleukin 1β-converting enzyme inhibitor-insensitive degradation of lamin B1 and DNA fragmentation in isolated thymocyte nuclei.
J Biol Chem
271
1996
22398
54
Henkart
PA
ICE family proteases: Mediators of all apoptotic cell death?
Cell
4
1996
195
Sign in via your Institution